NASDAQ:CYTK
$43.12
(
-0.301%
)
Friday, 27th Jan 2023
Cytokinetics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $40.18 | $46.77 | Friday, 27th Jan 2023 CYTK stock ended at $43.12. This is 0.301% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 2.28% from a day low at $43.05 to a day high of $44.03. |
| 90 days | $35.35 | $47.49 | |
| 52 weeks | $29.67 | $55.80 |
Historical Cytokinetics prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $43.31 | $44.03 | $43.05 | $43.12 | 405 915 |
| 2023-01-26 | $43.07 | $43.49 | $42.45 | $43.25 | 494 630 |
| 2023-01-25 | $43.21 | $43.66 | $42.77 | $42.96 | 1 066 624 |
| 2023-01-24 | $42.23 | $43.56 | $41.68 | $43.15 | 1 197 866 |
| 2023-01-23 | $41.88 | $42.26 | $40.26 | $42.20 | 1 498 768 |
| 2023-01-20 | $42.41 | $42.41 | $41.11 | $41.79 | 684 300 |
| 2023-01-19 | $42.61 | $43.19 | $41.89 | $41.93 | 776 407 |
| 2023-01-18 | $42.97 | $43.61 | $41.98 | $42.52 | 532 821 |
| 2023-01-17 | $42.89 | $43.00 | $41.93 | $42.72 | 639 200 |
| 2023-01-13 | $42.68 | $43.58 | $41.89 | $42.46 | 780 522 |
| 2023-01-12 | $41.03 | $42.91 | $40.18 | $42.82 | 925 408 |
| 2023-01-11 | $43.27 | $43.27 | $41.20 | $41.27 | 1 060 500 |
| 2023-01-10 | $42.24 | $43.65 | $42.24 | $43.42 | 920 505 |
| 2023-01-09 | $43.48 | $43.50 | $42.22 | $42.30 | 820 500 |
| 2023-01-06 | $42.65 | $43.40 | $41.86 | $43.15 | 786 220 |
| 2023-01-05 | $42.31 | $42.81 | $41.68 | $42.53 | 977 204 |
| 2023-01-04 | $44.42 | $44.68 | $42.60 | $42.70 | 941 153 |
| 2023-01-03 | $45.97 | $46.23 | $43.65 | $44.35 | 1 006 047 |
| 2022-12-30 | $45.28 | $45.91 | $44.69 | $45.82 | 940 306 |
| 2022-12-29 | $45.91 | $46.77 | $45.24 | $45.69 | 711 684 |
| 2022-12-28 | $45.46 | $46.75 | $44.88 | $45.60 | 824 346 |
| 2022-12-27 | $45.56 | $45.69 | $44.91 | $45.19 | 539 456 |
| 2022-12-23 | $46.91 | $47.09 | $45.03 | $45.59 | 661 195 |
| 2022-12-22 | $45.03 | $47.49 | $44.03 | $47.41 | 1 111 542 |
| 2022-12-21 | $44.30 | $45.98 | $43.36 | $45.12 | 890 433 |
| 2022-12-20 | $44.77 | $45.49 | $44.04 | $44.46 | 1 430 017 |
| 2022-12-19 | $43.76 | $44.31 | $42.38 | $44.02 | 1 291 490 |
| 2022-12-16 | $42.55 | $44.81 | $42.23 | $43.71 | 3 055 936 |
| 2022-12-15 | $41.41 | $43.43 | $40.81 | $43.10 | 1 723 079 |
| 2022-12-14 | $38.56 | $42.70 | $38.50 | $41.41 | 2 716 668 |
| 2022-12-13 | $38.05 | $38.05 | $38.05 | $38.05 | 0 |
| 2022-12-12 | $35.80 | $38.94 | $35.65 | $38.33 | 1 855 219 |
| 2022-12-09 | $36.11 | $38.99 | $35.61 | $35.77 | 3 416 899 |
| 2022-12-08 | $37.57 | $37.62 | $35.35 | $36.00 | 1 479 708 |
| 2022-12-07 | $36.86 | $37.61 | $36.67 | $37.04 | 1 290 119 |
| 2022-12-06 | $38.26 | $38.54 | $36.93 | $37.00 | 1 132 241 |
| 2022-12-05 | $40.33 | $40.33 | $37.78 | $38.12 | 1 686 163 |
| 2022-12-02 | $40.74 | $40.94 | $39.79 | $40.49 | 1 090 116 |
| 2022-12-01 | $42.23 | $42.69 | $40.72 | $40.86 | 833 660 |
| 2022-11-30 | $40.96 | $42.66 | $40.46 | $42.50 | 1 501 685 |
| 2022-11-29 | $40.21 | $41.01 | $39.91 | $40.46 | 858 853 |
| 2022-11-28 | $40.56 | $41.29 | $39.80 | $40.09 | 730 458 |
| 2022-11-25 | $40.26 | $41.00 | $40.00 | $40.68 | 295 828 |
| 2022-11-23 | $40.25 | $40.66 | $39.11 | $40.51 | 508 545 |
| 2022-11-22 | $40.28 | $40.28 | $39.21 | $40.05 | 586 156 |
| 2022-11-21 | $41.25 | $41.25 | $39.66 | $39.90 | 601 467 |
| 2022-11-18 | $41.36 | $41.50 | $40.01 | $40.95 | 616 608 |
| 2022-11-17 | $39.86 | $40.52 | $39.31 | $40.13 | 443 268 |
| 2022-11-16 | $39.90 | $40.98 | $39.39 | $39.61 | 403 541 |
| 2022-11-15 | $40.88 | $41.02 | $39.53 | $40.29 | 326 047 |
About Cytokinetics
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
